COVID-19

MedTech

Quest predicts 80% drop in 2023 COVID-19 test revenues

Quest's 2022 COVID-19 revenues were barely half the size of the previous year’s—and it's expecting 2023’s haul to shrink to an even smaller fraction.
Andrea Park Feb 6, 2023 10:33am

BD ups outlook amid stagnant base business, COVID testing crash

Feb 2, 2023 1:06pm

With COVID windfalls fading, Hologic eyes more tuck-in deals

Feb 2, 2023 11:40am

Siemens' diagnostics division falls 24% in COVID-light Q1

Feb 2, 2023 11:14am

Thermo Fisher revenues jump 15% in 2022

Feb 1, 2023 11:19am

CureVac posts mRNA flu, COVID-19 vaccine data in older adults

Jan 30, 2023 9:35am
More News

Altamira stakes for-sale sign again after asset deal crumbles

Jan 27, 2023 11:24am

Abbott ekes out 1.3% growth in 2022 amid COVID testing drop-off

Jan 25, 2023 12:13pm

BioNTech not giving up on fighting symptomatic COVID

Jan 10, 2023 4:18pm

JPM23: What testmakers like Freenome are taking away from COVID

Jan 10, 2023 10:10am